Laverock Therapeutics Awarded in Excess of £2.2M Through Two Innovation Grants to Support AI-powered Platform Development and to Expand Therapeutic Programmes Outside of Oncology
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
| The Manila Times